These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 4821783

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical and pharmacological evaluation of the effects of piribedil in patients with parkinsonism.
    McLellan DL, Chalmers RJ, Johnson RH.
    Acta Neurol Scand; 1975 Jan; 51(1):74-82. PubMed ID: 1091122
    [Abstract] [Full Text] [Related]

  • 3. Levodopa and dopamine in cerebrospinal fluid.
    Papavasiliou PS, Cotzias GC, Lawrence WH.
    Neurology; 1973 Jul; 23(7):756-9. PubMed ID: 4736493
    [No Abstract] [Full Text] [Related]

  • 4. Interactions of L-dopa and amantadine in patients with Parkinsonism.
    Cox B, Danta G, Schnieden H, Yuill GM.
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):354-61. PubMed ID: 4714097
    [Abstract] [Full Text] [Related]

  • 5. Comparison of amantadine, placebo, and levodopa in Parkinson's disease.
    Bauer RB, McHenry JT.
    Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417
    [No Abstract] [Full Text] [Related]

  • 6. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.
    Rinne UK, Sonninen V, Siirtola T.
    Eur Neurol; 1973 Aug; 9(6):349-62. PubMed ID: 4712542
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Monoamine metabolism and depression in Parkinson patients.
    Puite JK, Schut T, van Praag HM, Lakke JP.
    Psychiatr Neurol Neurochir; 1973 Aug; 76(1):61-70. PubMed ID: 4699106
    [No Abstract] [Full Text] [Related]

  • 10. Brain dopamine turnover and the relief of parkinsonism.
    Rinne UK, Sonninen V, Marttila R.
    Adv Exp Med Biol; 1977 Aug; 90():267-75. PubMed ID: 930747
    [Abstract] [Full Text] [Related]

  • 11. Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.
    Korf J, van Praag HM, Schut D, Nienhuis RJ, Lakke JP.
    Eur Neurol; 1974 Aug; 12(5-6):340-50. PubMed ID: 4448192
    [No Abstract] [Full Text] [Related]

  • 12. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
    Gumpert J, Sharpe D, Curzon G.
    J Neurol Sci; 1973 May; 19(1):1-12. PubMed ID: 4715017
    [No Abstract] [Full Text] [Related]

  • 13. Fusaric acid in Parkinson's disease.
    Chase TN.
    Neurology; 1974 Jul; 24(7):637-9. PubMed ID: 4858086
    [No Abstract] [Full Text] [Related]

  • 14. Amantadine in Parkinson's disease. A double-blind, placebo-controlled, crossover study with long-term follow-up.
    Butzer JF, Silver DE, Sahs AL.
    Neurology; 1975 Jul; 25(7):603-6. PubMed ID: 807867
    [Abstract] [Full Text] [Related]

  • 15. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.
    Lal S, De la Vega C, Garelis E, Sourkes TL.
    Psychiatr Neurol Neurochir; 1973 Jul; 76(2):113-7. PubMed ID: 4267059
    [No Abstract] [Full Text] [Related]

  • 16. Piribedil, a dopamine agonist, in Parkinson's disease.
    Sweet RD, Wasterlain CG, McDowell FH.
    Clin Pharmacol Ther; 1974 Dec; 16(6):1077-82. PubMed ID: 4611465
    [No Abstract] [Full Text] [Related]

  • 17. The probenecid test in Parkinson's disease.
    Lakke JP, Korf J, Hoorntje S, Schut T, van Praag HM.
    Psychiatr Neurol Neurochir; 1973 Dec; 76(2):139-46. PubMed ID: 4700931
    [No Abstract] [Full Text] [Related]

  • 18. Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa.
    Parkes JD, Marsden CD, Rees JE, Curzon G, Kantamaneni BD, Knill-Jones R, Akbar A, Das S, Kataria M.
    Q J Med; 1974 Jan; 43(169):49-61. PubMed ID: 4822972
    [No Abstract] [Full Text] [Related]

  • 19. Central monoamine metabolism in Parkinson's disease.
    Chase TN, Ng LK.
    Arch Neurol; 1972 Dec; 27(6):486-91. PubMed ID: 5083866
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA, Dowson JH, Ahmed R, Chow R, Gillingham FJ.
    Confin Neurol; 1972 Dec; 34(2):143-8. PubMed ID: 4666057
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.